Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 May;100(1):168–172. doi: 10.1111/j.1476-5381.1990.tb12071.x

Contractile activity of three endothelins (ET-1, ET-2 and ET-3) on the human isolated bronchus.

C Advenier 1, B Sarria 1, E Naline 1, L Puybasset 1, V Lagente 1
PMCID: PMC1917457  PMID: 1695532

Abstract

1. The effects of three endothelins: (i) the classical or human/porcine endothelin (ET-1); (ii) [Trp6, Leu7] endothelin (ET-2) and (iii) [Thr2, Phe4, Thr5, Tyr6, Lys7, Tyr14] endothelin or rat endothelin (ET-3) were tested on the human isolated bronchus. 2. ET-1 produced a concentration-dependent contraction of the human isolated bronchus that proceeded in two different steps. The first step was observed at very low concentrations (pD2 = 11.01 +/- 0.17, n = 10) but corresponded to a low intrinsic activity (Emax = 15.6 +/- 1.8% of Emax = 26.1 +/- 2.9% of ACh 3 x 10(-3) M, n = 5, P less than 0.05), reduced by nicardipine 10(-6) M (Emax = 6.0 +/- 2.6% of ACh 3 x 10(-3) M, n = 5, P less than 0.05) and strongly inhibited in calcium-free medium. The second step of the action of ET-1 corresponded to a lesser potency (pD2 = 7.90 +/- 0.17, n = 9) but a higher intrinsic activity (Emax = 82.5 +/- 4.7% of ACh 3 x 10(-3) M). This effect was not significantly modified by nicardipine 10(-6) M or by Bay K 8644 10(-7) M. Neither of the two effects was modified by indomethacin 3 x 10(-6) M. 3. The effects of ET-2 and ET-3 were qualitatively similar to those of ET-1 but quantitatively different; for these two steps of contracting activity and for potency and efficacy the ranking was: ET-1 greater than ET-2 = ET-3.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
171

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Advenier C., Cerrina J., Duroux P., Floch A., Renier A. Effects of five different organic calcium antagonists on guinea-pig isolated trachea. Br J Pharmacol. 1984 Jul;82(3):727–733. doi: 10.1111/j.1476-5381.1984.tb10812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Advenier C., Naline E., Renier A. Effects of Bay K 8644 on contraction of the human isolated bronchus and guinea-pig isolated trachea. Br J Pharmacol. 1986 May;88(1):33–39. doi: 10.1111/j.1476-5381.1986.tb09468.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Allen S. L., Foster R. W., Small R. C., Towart R. The effects of the dihydropyridine Bay K 8644 in guinea-pig isolated trachealis. Br J Pharmacol. 1985 Sep;86(1):171–180. doi: 10.1111/j.1476-5381.1985.tb09447.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borges R., Von Grafenstein H., Knight D. E. Tissue selectivity of endothelin. Eur J Pharmacol. 1989 Jun 20;165(2-3):223–230. doi: 10.1016/0014-2999(89)90716-4. [DOI] [PubMed] [Google Scholar]
  5. Braquet P., Touvay C., Lagente V., Vilain B., Pons F., Hosford D., Chabrier P. E., Mencia-Huerta J. M. Effect of endothelin-1 on blood pressure and bronchopulmonary system of the guinea pig. J Cardiovasc Pharmacol. 1989;13 (Suppl 5):S143–S150. doi: 10.1097/00005344-198900135-00036. [DOI] [PubMed] [Google Scholar]
  6. De Jongste J. C., Mons H., Block R., Bonta I. L., Frederiksz A. P., Kerrebijn K. F. Increased in vitro histamine responses in human small airways smooth muscle from patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1987 Mar;135(3):549–553. doi: 10.1164/arrd.1987.135.3.549. [DOI] [PubMed] [Google Scholar]
  7. Douglas J. S., Brink C. Airway smooth muscle and disease workshop: histamine and prostanoids. Am Rev Respir Dis. 1987 Oct;136(4 Pt 2):S21–S24. doi: 10.1164/ajrccm/136.4_Pt_2.S21. [DOI] [PubMed] [Google Scholar]
  8. Foster R. W., Small R. C., Weston A. H. Evidence that the spasmogenic action of tetraethylammonium in guinea-pig trachealis is both direct and dependent on the cellular influx of calcium ion. Br J Pharmacol. 1983 May;79(1):255–263. doi: 10.1111/j.1476-5381.1983.tb10519.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Foster R. W., Small R. C., Weston A. H. The spasmogenic action of potassium chloride in guinea-pig trachealis. Br J Pharmacol. 1983 Nov;80(3):553–559. doi: 10.1111/j.1476-5381.1983.tb10728.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Godfraind T., Kaba A., Polster P. Differences in sensitivity of arterial smooth muscles to inhibition of their contractile response to depolarization by potassium. Arch Int Pharmacodyn Ther. 1968 Mar;172(1):235–239. [PubMed] [Google Scholar]
  11. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kanse S. M., Ghatei M. A., Bloom S. R. Endothelin binding sites in porcine aortic and rat lung membranes. Eur J Biochem. 1989 Jun 1;182(1):175–179. doi: 10.1111/j.1432-1033.1989.tb14814.x. [DOI] [PubMed] [Google Scholar]
  13. Kozuka M., Ito T., Hirose S., Takahashi K., Hagiwara H. Endothelin induces two types of contractions of rat uterus: phasic contractions by way of voltage-dependent calcium channels and developing contractions through a second type of calcium channels. Biochem Biophys Res Commun. 1989 Feb 28;159(1):317–323. doi: 10.1016/0006-291x(89)92440-6. [DOI] [PubMed] [Google Scholar]
  14. Lagente V., Chabrier P. E., Mencia-Huerta J. M., Braquet P. Pharmacological modulation of the bronchopulmonary action of the vasoactive peptide, endothelin, administered by aerosol in the guinea-pig. Biochem Biophys Res Commun. 1989 Feb 15;158(3):625–632. doi: 10.1016/0006-291x(89)92767-8. [DOI] [PubMed] [Google Scholar]
  15. Macquin-Mavier I., Levame M., Istin N., Harf A. Mechanisms of endothelin-mediated bronchoconstriction in the guinea pig. J Pharmacol Exp Ther. 1989 Aug;250(2):740–745. [PubMed] [Google Scholar]
  16. Maggi C. A., Giuliani S., Patacchini R., Santicioli P., Rovero P., Giachetti A., Meli A. The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Eur J Pharmacol. 1989 Jul 4;166(1):121–122. doi: 10.1016/0014-2999(89)90693-6. [DOI] [PubMed] [Google Scholar]
  17. Maggi C. A., Patacchini R., Giuliani S., Meli A. Potent contractile effect of endothelin in isolated guinea-pig airways. Eur J Pharmacol. 1989 Jan 24;160(1):179–182. doi: 10.1016/0014-2999(89)90670-5. [DOI] [PubMed] [Google Scholar]
  18. Marsden P. A., Danthuluri N. R., Brenner B. M., Ballermann B. J., Brock T. A. Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. Biochem Biophys Res Commun. 1989 Jan 16;158(1):86–93. doi: 10.1016/s0006-291x(89)80180-9. [DOI] [PubMed] [Google Scholar]
  19. Minkes R. K., Coy D. H., Murphy W. A., McNamara D. B., Kadowitz P. J. Effects of porcine and rat endothelin and an analog on blood pressure in the anesthetized cat. Eur J Pharmacol. 1989 May 30;164(3):571–575. doi: 10.1016/0014-2999(89)90266-5. [DOI] [PubMed] [Google Scholar]
  20. Naline E., Devillier P., Drapeau G., Toty L., Bakdach H., Regoli D., Advenier C. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis. 1989 Sep;140(3):679–686. doi: 10.1164/ajrccm/140.3.679. [DOI] [PubMed] [Google Scholar]
  21. Ohlstein E. H., Horohonich S., Hay D. W. Cellular mechanisms of endothelin in rabbit aorta. J Pharmacol Exp Ther. 1989 Aug;250(2):548–555. [PubMed] [Google Scholar]
  22. Payne A. N., Whittle B. J. Potent cyclo-oxygenase-mediated bronchoconstrictor effects of endothelin in the guinea-pig in vivo. Eur J Pharmacol. 1988 Dec 13;158(3):303–304. doi: 10.1016/0014-2999(88)90085-4. [DOI] [PubMed] [Google Scholar]
  23. Rodman D. M., McMurtry I. F., Peach J. L., O'Brien R. F. Comparative pharmacology of rat and porcine endothelin in rat aorta and pulmonary artery. Eur J Pharmacol. 1989 Jun 20;165(2-3):297–300. doi: 10.1016/0014-2999(89)90724-3. [DOI] [PubMed] [Google Scholar]
  24. Uchida Y., Ninomiya H., Saotome M., Nomura A., Ohtsuka M., Yanagisawa M., Goto K., Masaki T., Hasegawa S. Endothelin, a novel vasoconstrictor peptide, as potent bronchoconstrictor. Eur J Pharmacol. 1988 Sep 13;154(2):227–228. doi: 10.1016/0014-2999(88)90106-9. [DOI] [PubMed] [Google Scholar]
  25. Xuan Y. T., Whorton A. R., Watkins W. D. Inhibition by nicardipine of endothelin-mediated inositol phosphate formation and Ca2+ mobilization in smooth muscle cell. Biochem Biophys Res Commun. 1989 Apr 28;160(2):758–764. doi: 10.1016/0006-291x(89)92498-4. [DOI] [PubMed] [Google Scholar]
  26. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES